Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Active not recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 131Lymphoma 117Lymphoma, Large B-Cell, Diffuse 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Multiple Myeloma 50Lymphoma, Non-Hodgkin 46Lymphoma, Follicular 45Leukemia 39Hodgkin Disease 33Lymphoma, Mantle-Cell 32Burkitt Lymphoma 32Lymphoma, Large-Cell, Immunoblastic 21Lymphoma, Large-Cell, Anaplastic 20Lymphoma, B-Cell, Marginal Zone 19Neoplasm Metastasis 16Leukemia, Lymphocytic, Chronic, B-Cell 16Neoplasms, Plasma Cell 15Neoplasms 13Lymphoma, T-Cell, Peripheral 10Dendritic Cell Sarcoma, Interdigitating 10Recurrence 9Lymphoma, B-Cell 9Primary Myelofibrosis 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Immunoblastic Lymphadenopathy 8Blast Crisis 7Lymphoma, T-Cell 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Prostate Cancer Metastatic 5

Interventions

Vincristine 2Inotuzumab Ozogamicin 2Doxorubicin 2Dexamethasone 2Cyclophosphamide 2pegaspargase 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1azathiopurine 1auricularum 1Thioguanine 1Prednisone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Lenalidomide 1Etoposide 1Cytarabine 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Prednisone × Clear all
NCT03991884 2023-07-06

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

University of Washington

Phase 1 Completed
24 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡